Human TH17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation
Open accessThe DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Abstract
T(H)17 lymphocytes appear to be essential in the pathogenesis of numerous inflammatory diseases. We demonstrate here the expression of IL-17 and IL-22 receptors on blood-brain barrier endothelial cells (BBB-ECs) in multiple sclerosis lesions, and show that IL-17 and IL-22 disrupt BBB tight junctions in vitro and in vivo. Furthermore, T(H)17 lymphocytes transmigrate efficiently across BBB-ECs, highly express granzyme B, kill human neurons and promote central nervous system inflammation through CD4+ lymphocyte recruitment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In turn, IL-17 further impairs BBB integrity, thus allowing more immune cells and cytokines to gain easy access to the CNS [65, 66].”
From Chronic stress-induced depression requires the recruitment of peripheral Th17 cells into the brain (2022) · cites this paper as [66]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“IL-17 impairs blood–brain barrier integrity, allowing for more immune cells to cross into the CNS [127,128].”
From The Role of Cortisol in Chronic Stress, Neurodegenerative Diseases, and Psychological Disorders (2023) · cites this paper as [128]
The cited source says what the claim attributes to it.
In the citing paper
“a subset of CD4+ T cells that is a major contributor to the pathogenicity of several inflammatory and autoimmune conditions (9–11)”
From Inflammatory T helper 17 cells promote depression-like behavior in mice (2013) · cites this paper as [10]
The cited source says what the claim attributes to it.
In the citing paper
“inflammatory subtypes of T cells, particularly Th17 cells, are clearly deleterious in diseases such as multiple sclerosis (9–11, 24)”
From Inflammatory T helper 17 cells promote depression-like behavior in mice (2013) · cites this paper as [10]
The cited source says what the claim attributes to it.
In the citing paper
“Th17 cells are deleterious to the CNS”
From Inflammatory T helper 17 cells promote depression-like behavior in mice (2013) · cites this paper as [10]
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
IL-23 drives a pathogenic T cell population that induces autoimmune inflammation
Langrish, C. L., Chen, Y., Blumenschein, W. M., Mattson, J., Basham, B., Sedgwick, J. D., McClanahan, T., Kastelein, R. A., & Cua, D. J. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20041257 · Cited by 4,099
Cua, D. J., Sherlock, J., Chen, Y., Murphy, C. A., Joyce, B., Seymour, B., Lucian, L., To, W., Kwan, S., Churakova, T., et al. (2003) · Nature · doi:10.1038/nature01355 · Cited by 2,906
Liang, S. C., Tan, X.-Y., Luxenberg, D. P., Karim, R., Dunussi-Joannopoulos, K., Collins, M., & Fouser, L. A. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20061308 · Cited by 2,330
Immunology of multiple sclerosis
Sospedra, M., & Martin, R. (2005) · Annual Review of Immunology · doi:10.1146/annurev.immunol.23.021704.115707 · Cited by 2,149
Interleukin-22, a TH17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis
Zheng, Y., Danilenko, D. M., Valdez, P., Kasman, I., Eastham-Anderson, J., Wu, J., & Ouyang, W. (2007) · Nature · doi:10.1038/nature05505 · Cited by 1,862
IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis
Komiyama, Y., Nakae, S., Matsuki, T., Nambu, A., Ishigame, H., Kakuta, S., Sudo, K., & Iwakura, Y. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.1.566 · Cited by 1,536
Steinman, L. (2007) · Nature Medicine · doi:10.1038/nm1551 · Cited by 1,376
Loss of T-bet, But Not STAT1, Prevents the Development of Experimental Autoimmune Encephalomyelitis
Bettelli, E., Sullivan, B., Szabo, S. J., Sobel, R. A., Glimcher, L. H., & Kuchroo, V. K. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20031819 · Cited by 488
Wosik, K., Cayrol, R., Dodelet-Devillers, A., Berthelet, F., Bernard, M., Moumdjian, R., Bouthillier, A., Reudelhuber, T. L., & Prat, A. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.2088-07.2007 · Cited by 259
Self-citationExpression and regulation of IL-22 in the IL-17-producing CD4+ T lymphocytes
Chung, Y., Yang, X., Chang, S. H., Ma, L., Tian, Q., & Dong, C. (2006) · Cell Research · doi:10.1038/sj.cr.7310106 · Cited by 231
Cited by
Items 801–900 of 1,003
Alzheimer’s disease: The role of T lymphocytes in neuroinflammation and neurodegeneration
Asamu, M. O., Oladipo, O. O., Abayomi, O. A., & Adebayo, A. A. (2023) · Brain Research · doi:10.1016/j.brainres.2023.148589 · Cited by 37
Jiang, Z., Li, H., Fitzgerald, D. C., Zhang, G., & Rostami, A. M. (2009) · European Journal of Immunology · doi:10.1002/eji.200838427 · Cited by 31
“IL-17 production is significantly elevated in MS patients and in EAE mouse models [33-36].”
BackgroundDendritic Cells and Multiple Sclerosis: Disease, Tolerance and Therapy
Mohammad, M. G., Hassanpour, M., Tsai, V. W.-W., Li, H., Ruitenberg, M. J., Booth, D. R., Serrats, J., Hart, P. H., Symonds, G., Sawchenko, P. E., et al. (2012) · International Journal of Molecular Sciences · doi:10.3390/ijms14010547 · Cited by 39
The Molecular Mechanisms of Vitamin A Deficiency in Multiple Sclerosis
Motlagh, A. D., Honarvar, N. M., Sedighiyan, M., & Abdolahi, M. (2016) · Journal of Molecular Neuroscience · doi:10.1007/s12031-016-0781-0 · Cited by 38
“2009), and IL-17 is known to promote BBB permeability to proinflammatory mediators (Kebir et al. 2007; Buc 2013).”
BackgroundKlotz, L., Kuzmanov, I., Hucke, S., Groß, C. C., Posevitz, V., Dreykluft, A., Schulte‐Mecklenbeck, A., Janoschka, C., Lindner, M., Herold, M. V. B., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1601350113 · Cited by 36
“(31) described pronounced granzyme B expression by these human TH17 cells.”
BackgroundTrichuris suis secrete products that reduce disease severity in a multiple sclerosis model
Hansen, C. S., Hasseldam, H., Bacher, I. H., Thamsborg, S. M., Johansen, F. F., & Kringel, H. (2016) · Acta Parasitologica · doi:10.1515/ap-2017-0002 · Cited by 33
“Disease *Corresponding author: henrik.hasseldam@bric.ku.dk †The authors contributed equally as the first author Author's copy exacerbation of MS has been linked to T H 17 cells infiltrating the CNS (Kebir et al. 2009), and although no specific cytokine of the T H 17 lineage has been found to be key for development of…”
BackgroundInfluentialDetection of IL-17A-producing peripheral blood monocytes in Langerhans cell histiocytosis patients
Lourda, M., Olsson‐Åkefeldt, S., Gavhed, D., Björnfot, S., Clausen, N., Hjalmars, U., Sabel, M., Tazi, A., Aricò, M., Delprat, C., et al. (2014) · Clinical Immunology · doi:10.1016/j.clim.2014.04.004 · Cited by 35
Gao, D., Zou, B., Zhu, K., Bi, S., Zhang, W., Yang, X., Lai, J., Liang, G., & Pan, P. (2024) · Journal of Neuroinflammation · doi:10.1186/s12974-024-03252-y · Cited by 32
“Th17 cells and inflammatory mediators like IL-17 are markedly increased in the brain after bleeding [10].”
BackgroundBlaževski, J., Petković, F., Momčilović, M. B., Paschke, R., Kaluđerović, G. N., Stojković, M. M., & Miljković, D. M. (2013) · Acta Pharmacologica Sinica · doi:10.1038/aps.2012.181 · Cited by 30
High salt-induced activation and expression of inflammatory cytokines in cultured astrocytes
Deng, Z., Wang, Y., Zhou, L., Shan, Y., Tan, S., Cai, W., Liao, S., Peng, L., & Lu, Z. (2017) · Cell Cycle · doi:10.1080/15384101.2017.1301330 · Cited by 32
“In addition, HS can also enhance blood brain barrier (BBB) disruption, increase leukocytes infltration and down-regulate tight junction (TJ) proteins expression.(12)”
BackgroundEffects of Acupuncture on Gait of Patients with Multiple Sclerosis
Criado, M. B., Santos, M. J., Machado, J. P., Gonçalves, A. M., & Greten, H. J. (2017) · The Journal of Alternative and Complementary Medicine · doi:10.1089/acm.2016.0355 · Cited by 37
RKIP mediates autoimmune inflammation by positively regulating IL‐17R signaling
Lin, W., Wang, N., Zhou, K., Su, F., Jiang, Y., Shou, J., Liu, H., Ma, C., Qian, Y., Wang, K., et al. (2018) · EMBO Reports · doi:10.15252/embr.201744951 · Cited by 30
“Upon the binding of IL-17A or IL-17F to the homodimer or hetero-dimer IL-17R (IL-17RA or IL-17RA/F), IL-17R recruits the key adaptor protein Act1 (also known as CIKS, an E3 ubiquitinase) to the cytoplasmic tail of IL-17R and activates both MAPK and NF-j B signaling to induce proinflammatory cytokine and chemokine prod…”
Digoxin, an Overlooked Agonist of RORγ/RORγT
Karaś, K., Sałkowska, A., Sobalska‐Kwapis, M., Walczak‐Drzewiecka, A., Strapagiel, D., Dastych, J., Bachorz, R. A., & Ratajewski, M. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.01460 · Cited by 33
“…autoimmunological diseases, e.g., rheumatoid arthritis (Hirota et al., 2007), Graves’ disease (Zheng et al., 2013), and multiple sclerosis (Kebir et al., 2007), RORγT is perceived as a promising target in the development of new pharmaceuticals for the treatment of autoimmunological…”
BackgroundLotfi, R., Kalmarzi, R. N., Rajabinejad, M., Hasani, S., & Zamani, F. (2021) · International Immunopharmacology · doi:10.1016/j.intimp.2021.107556 · Cited by 31
Zhao, Y., Liu, Z., Qin, L., Wang, T., & Bai, O. (2021) · Molecular Immunology · doi:10.1016/j.molimm.2021.03.010 · Cited by 31
Kalinowska, A., Szczuciński, A., Pawlak, M. A., & Losy, J. (2010) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2010.09.026 · Cited by 33
“Moreover, T(H)-17 cells have recently been shown to transmigrate efficiently across blood−brain barrier endothelial cells, promoting CNS inflammation through CD4+ lymphocytes recruitment [21].”
BackgroundTargeting sphingosine-1-phosphate signaling for cancer therapy
Xie, Z., Liu, H., & Geng, M. (2017) · Science China Life Sciences · doi:10.1007/s11427-017-9046-6 · Cited by 31
Chen, J., Martindale, J. L., Cramer, C. L., Gorospe, M., Atasoy, U., Drew, P. D., & Yu, S. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m117.782771 · Cited by 33
LFA-1 Controls Th1 and Th17 Motility Behavior in the Inflamed Central Nervous System
Dusi, S., Angiari, S., Pietronigro, E. C., Lopez, N., Angelini, G., Zenaro, E., Bianca, V. D., Tosadori, G., Paris, F., Amoruso, A., et al. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02436 · Cited by 33
Ahmad, S. F., Ansari, M. A., Nadeem, A., Bakheet, S. A., Alsanea, S., Alhosaini, K. A., Mahmood, H. M., Alzahrani, M. Z., & Attia, S. M. (2019) · NeuroToxicology · doi:10.1016/j.neuro.2019.12.003 · Cited by 31
Molecular Pathogenesis and Interventional Strategies for Alzheimer’s Disease: Promises and Pitfalls
Bhute, S., Sarmah, D., Datta, A., Rane, P., Shard, A., Goswami, A., Borah, A., Kalia, K., Dave, K. R., & Bhattacharya, P. (2020) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.9b00104 · Cited by 34
Li, Q., Ding, S., Wang, Y. M., Xu, X., Shen, Z., Fu, R., Liu, M., Hu, C., Zhang, C., Cao, Q., et al. (2017) · Europe PMC (PubMed Central) · Cited by 30
Pregnancy-induced fluctuations in functional T-cell subsets in multiple sclerosis patients
Neuteboom, R. F., Verbraak, E., Wierenga‐Wolf, A. F., van Meurs, M., Steegers, E. A. P., de Groot, C. J. M., Laman, J. D., & Hintzen, R. Q. (2010) · Multiple Sclerosis Journal · doi:10.1177/1352458510373939 · Cited by 31
“involved in the promotion of blood–brain barrier disruption and brain inflammation.(4) Another important T-cell subset in MS are the immunosuppressive regulatory T cells (Treg), the central role of which has been demonstrated in the maintenance of self-tolerance in autoimmune animal models.”
BackgroundDeleterious versus protective autoimmunity in multiple sclerosis
Kostić, M. S., Stojanović, I. R., Marjanović, G., Živković, N., & Cvetanović, A. (2015) · Cellular Immunology · doi:10.1016/j.cellimm.2015.04.006 · Cited by 32
Sewell, M. D. E., Sánchez, L. J., Shen, X., Edmondson-Stait, A. J., Green, C., Adams, M. J., Rifai, O. M., McIntosh, A. M., Lyall, D. M., Whalley, H. C., et al. (2021) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2021.06.002 · Cited by 35
Balzano, T., Leone, P., Mincheva, G., Castro, M. C., Reyes, L., Ramón, C., Malaguarnera, M., Llansola, M., & Felipo, V. (2021) · Biomedicines · doi:10.3390/biomedicines9081002 · Cited by 34
“Once activated, CD4+CD28− and Th17 lymphocytes can migrate into the brain and initiate a pro-inflammatory response [56,57].”
BackgroundMicroglia express a functional receptor for interleukin-23
Sonobe, Y., Liang, J., Jin, S., Zhang, G., Takeuchi, H., Mizuno, T., & Suzumura, A. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.03.059 · Cited by 29
“Furthermore, the Th17 cytokines IL-17 and IL-22 disrupt the tight junction of blood–brain barrier [26].”
BackgroundT h1‐mediated experimental autoimmune encephalomyelitis is CXCR 3 independent
Lalor, S. J., & Segal, B. M. (2013) · European Journal of Immunology · doi:10.1002/eji.201343499 · Cited by 32
Lower frequency of IL-17F sequence variant (His161Arg) in chronic fatigue syndrome patients
Metzger, K., Frémont, M., Roelant, C., & Meirleir, K. D. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.08.135 · Cited by 29
Goettel, J. A., Algood, H. M. S., Olivares–Villagómez, D., Washington, M. K., Chaturvedi, R., Wilson, K. T., Kaer, L. V., & Polk, D. B. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.09.041 · Cited by 29
Uemura, Y., Liu, T.-Y., Narita, Y., Suzuki, M., Nakatsuka, R., Araki, T., Matsumoto, M., Iwai, L. K., Hirosawa, N., Matsuoka, Y., et al. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0900873 · Cited by 30
Spinello, C., Laviola, G., & Macrì, S. (2016) · Frontiers in Neuroscience · doi:10.3389/fnins.2016.00310 · Cited by 28
“IL17 causes the damaging of BBB barrier through the production of reactive oxygen species (ROS) in endothelial cells (Kebir et al., 2007; Huppert et al., 2010).”
BackgroundGonczi, C. M. C., Tabatabaei, M., East, A., Martire, E., Maurice-Ventouris, M. E. I., & Darlington, P. J. (2017) · FEBS Journal · doi:10.1111/febs.14166 · Cited by 32
Teixeira, N. B., Sant’Anna, M. B., Giardini, A. C., Araújo, L. P., Fonseca, L. A., Basso, A. S., Cury, Y., & Picolo, G. (2019) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2019.12.009 · Cited by 29
Foulsham, W., Mittal, S. K., Taketani, Y., Chen, Y., Nakao, T., Chauhan, S. K., & Dana, R. (2020) · American Journal Of Pathology · doi:10.1016/j.ajpath.2020.03.016 · Cited by 29
“Th17 cells have emerged as key effector immune cells in DED, mirroring their immunopathogenic role in autoimmune conditions such as uveitis/scleritis,(28) rheumatoid arthritis,(29) inflammatory bowel disease,(30) and multiple sclerosis.(31) Experimental desiccating stresseinduced DED is a well-recognized preclinical m…”
BackgroundBiomarkers in the cerebrospinal fluid and neurodegeneration in Langerhans cell histiocytosis
Gavhed, D., Åkefeldt, S. O., Österlundh, G., Laurenčikas, E., Hjorth, L., Blennow, K., Rosengren, L., & Henter, J. (2009) · Pediatric Blood & Cancer · doi:10.1002/pbc.22238 · Cited by 29
“Since IL-17A recently has been identified in LCH lesions [1] and since T helper type 17 lymphocytes, which produce IL-17A, are known to promote blood–brain barrier disruption and induce CNS inflammation [36], it could be speculated that the complications are a result of IL-17A induced CNS inflammation.”
BackgroundTh9 and Th22 immune response in young patients with type 1 diabetes
Ryba-Stanisławowska, M. E., Werner, P., Brandt, A., Myśliwiec, M., & Myśliwska, J. M. (2015) · Immunologic Research · doi:10.1007/s12026-015-8765-7 · Cited by 30
T cells producing GM-CSF and IL-13 are enriched in the cerebrospinal fluid of relapsing MS patients
Ghezzi, L., Cantoni, C., Cignarella, F., Bollman, B., Cross, A. H., Salter, A. R., Galimberti, D., Cella, M., & Piccio, L. M. (2019) · Multiple Sclerosis Journal · doi:10.1177/1352458519852092 · Cited by 33
Hyperhomocysteinemia and Endothelial Dysfunction in Multiple Sclerosis
Александровна, Д. Е., Ivanov, A. V., Спирина, Н. Н., Смирнова, Н. Ф., Melnikov, M., Boyко, A., Gusev, E., & Kubatiev, A. A. (2020) · Brain Sciences · doi:10.3390/brainsci10090637 · Cited by 30
“The ability of Th17-cells to disturb BBB by producing pro-inflammatory IL-17 and migrate into CNS by the expression of chemokine receptor CCR-6 (CD196) was demonstrated [79,80].”
BackgroundGautam, A. S., Pulivarthi, C. B., & Singh, R. K. (2022) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-022-02357-6 · Cited by 33
Fine Mapping and Functional Analysis of the Multiple Sclerosis Risk Gene CD6
Swaminathan, B., Cuapio, A., Alloza, I., Matesanz, F., Alcina, A., García‐Barcina, M., Fedetz, M., Fernández, Ó., Lucas, M., Órpez, T., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0062376 · Cited by 35
“The ability of IL-17A to protect against development of autoimmune uveitis and ulcerative colitis [49,50] has been demonstrated; however, this contrasts with the reported disease-promoting role of Th17 cells in MS [51–53], and will need further clarification.”
ResultIvey, N. S., Renner, N. A., Moroney-Rasmussen, T., Mohan, M., Redmann, R., Didier, P., Alvarez, X., Lackner, A., & MacLean, A. G. (2009) · Journal of Neurovirology · doi:10.1080/13550280902998413 · Cited by 34
“Decreases in ZO-1 have been correlated with increased permeability of the tight junction, and BBB disruption (Chaudhuri et al, 2008; Kebir et al, 2007).”
Type17 T-cells in Central Nervous System Autoimmunity and Tumors
Okada, H., & Khoury, S. J. (2012) · Journal of Clinical Immunology · doi:10.1007/s10875-012-9686-z · Cited by 31
“The Th17-1 cells in MS patients appear to cross the BBB more efficiently [18].”
Role of TH-17 Cells in Rheumatic and Other Autoimmune Diseases
Volin, M. V., & Shahrara, S. (2011) · Rheumatology Current Research · doi:10.4172/2161-1149.1000104 · Cited by 30
“Endothelial cells of the blood brain barrier express receptors for IL-17 and IL-22 and it was shown that IL-17 and IL-22 could disrupt the blood brain barrier possibly through the production of reactive oxygen species [53,54].”
BackgroundRamgolam, V. S., & Markovic‐Plese, S. (2011) · Journal of Signal Transduction · doi:10.1155/2011/635721 · Cited by 32
“IL-17A together with IL-22 induces blood brain barrier permeability due to their effect on the endothelial cells [11].”
BackgroundRojo, J. M., Pini, E., Ojeda, G., Bello, R., Dong, C., Flavell, R. A., Dianzani, U., & Portolés, P. (2008) · International Immunology · doi:10.1093/intimm/dxn016 · Cited by 28
Markovic‐Plese, S., Singh, A. K., & Singh, I. (2008) · Future Neurology · doi:10.2217/14796708.3.2.153 · Cited by 29
“Recently, IL-17-producing cells have been recognized to play a critical role in autoimmunity [44,45].”
BackgroundModulation of T-cell Mediated Immunity by Dopamine Receptor D5
Prado, C. E., Bernales, S., & Pacheco, R. (2013) · Endocrine Metabolic & Immune Disorders - Drug Targets · doi:10.2174/1871530311313020007 · Cited by 30
Salehi, Z., Doosti, R., Beheshti, M., Janzamin, E., Sahraian, M. A., & Izad, M. H. (2016) · PLoS ONE · doi:10.1371/journal.pone.0159565 · Cited by 31
“Moreover, IL-22, along with IL-17, involved in pathology of MS by affecting the blood brain barrier (BBB) integrity [53].”
BackgroundUse of imaging to study leukocyte trafficking in the central nervous system
Zenaro, E., Rossi, B., Angiari, S., & Constantin, G. (2013) · Immunology and Cell Biology · doi:10.1038/icb.2012.81 · Cited by 31
Restraint stress modulates virus specific adaptive immunity during acute Theiler’s virus infection
Steelman, A. J., Dean, D. D., Young, C. R., Smith, R., Prentice, T. W., Meagher, M. W., & Welsh, C. J. (2009) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2009.03.010 · Cited by 30
“Indeed, recent evidence strongly suggests that these cells are actively involved in the pathogenesis of MS (Witowski et al., 2004; Vaknin-Dembinsky et al., 2006; Kebir et al., 2007; Ifergan et al., 2008).”
BackgroundBrain Barriers and Multiple Sclerosis: Novel Treatment Approaches from a Brain Barriers Perspective
Nishihara, H., & Engelhardt, B. (2020) · Handbook of experimental pharmacology · doi:10.1007/164_2020_407 · Cited by 28
Dynamic nanoassemblies for imaging and therapy of neurological disorders
Zhang, L., Sun, H., Zhao, J., Lee, J., Low, L. E., Gong, L., Chen, Y., Wang, N., Zhu, C., Lin, P., et al. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.113832 · Cited by 28
Momčilović, M. B., Miljković, Ž., Popadic, D. M., Marković, M., Savić, E., Ramić, Z., Miljković, D. M., & Mostarica‐Stojković, M. (2008) · BMC Immunology · doi:10.1186/1471-2172-9-47 · Cited by 27
“, as they showed that human blood-brain barrier (BBB) endothelial cells in MS lesions express receptors for IL-17, and that IL-17 disrupts BBB tight junctions both in vitro and in vivo [31].”
BackgroundT cell cytokine signatures: Biomarkers in pediatric multiple sclerosis
Cala, C. M., Moseley, C. E., Steele, C. H., Dowdy, S. M., Cutter, G., Ness, J., & DeSilva, T. M. (2016) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2016.04.015 · Cited by 27
“Differentiated effector T cells are considered the principal orchestrators in MS pathogenesis (Komiyama et al., 2006; Kebir et al., 2007).”
Luo, D., & Fu, J. X. (2018) · Oncotarget · doi:10.18632/oncotarget.23866 · Cited by 27
“It is well-known that T(H)17 lymphocytes, as a third subset of effector CD4 +T cells, were different from the classic lineages of Th1 and Th2 cells and played essential roles in the pathogenesis of MS [39].”
BackgroundCD4+ T-Cell Senescence in Neurodegenerative Disease: Pathogenesis and Potential Therapeutic Targets
Gao, Y., Lu, Y., Liang, X., Zhao, M., Yu, X., Fu, H., & Yang, W. (2024) · Cells · doi:10.3390/cells13090749 · Cited by 29
“Additionally, T-cell telomere length is negatively correlated with Research has found that in AD patients, AD disease indicators such as elevated”
BackgroundSustained immunotolerance in multiple sclerosis after stem cell transplant
Visweswaran, M., Hendrawan, K., Massey, J. C., Khoo, M. L. M., Ford, C., Zaunders, J., Withers, B., Sutton, I. J., Ma, D. D. F., & Moore, J. J. (2022) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.51510 · Cited by 31
Ahmad, S. F., Nadeem, A., Ansari, M. A., Bakheet, S. A., Shahid, M., Al‐Mazroua, H. A., Sobeai, H. M. A., Alasmari, A. F., Alanazi, M. M., Alhamed, A. S., et al. (2022) · Cellular Immunology · doi:10.1016/j.cellimm.2022.104580 · Cited by 26
Al‐Hakeim, H. K., Al-Musawi, A. F., Almulla, A. F., Al-Dujaili, A. H., Debnath, M., & Maes, M. H. J. (2022) · PLoS ONE · doi:10.1371/journal.pone.0275839 · Cited by 27
“Third, BBB endothelial cells express IL-17 and IL-22 receptors, and binding to IL-17 and IL-22 causes BBB permeabilization (95, 96), thereby aggravating the effects of LPS, other cytokines and tryptophan catabolites on BBB breakdown (97).”
BackgroundImmunity impacts cognitive deficits across neurological disorders
Shaw, B. C., Anders, V., Tinkey, R. A., Habean, M. L., Brock, O. D., Frostino, B. J., & Williams, J. L. (2023) · Journal of Neurochemistry · doi:10.1111/jnc.15999 · Cited by 44
“Using adoptively transferred EAE, substantial increases in TNF α protein in the hippocampus as well as fear conditioning deficits were observed corroborating pre - vious findings (Acharjee et al., 2013 ).”
InfluentialZhang, W., Zhang, P., Xu, L.-H., Gao, K., Zhang, J., Yao, M., Li, R., Guo, C., Wang, J., & Wu, Q. (2023) · Phytomedicine · doi:10.1016/j.phymed.2023.155237 · Cited by 26
TRPV1 Gates Tissue Access and Sustains Pathogenicity in Autoimmune Encephalitis
Paltser, G., Liu, X. J., Yantha, J., Winer, S., Tsui, H., Wu, P., Maezawa, Y., Cahill, L. S., Laliberté, C. L., Ramagopalan, S. V., et al. (2013) · Molecular Medicine · doi:10.2119/molmed.2012.00329 · Cited by 27
Williams, J. L., Kithcart, A. P., Smith, K. M., Shawler, T. M., Cox, G. M., & Whitacre, C. C. (2011) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2011.02.008 · Cited by 26
“Both Th1 andTh17 cells are implicated in thepathogenesis ofMS and EAE (Langrish et al., 2005; Kebir et al., 2007).”
BackgroundSamson, M., Lakomy, D., Audia, S., & Bonnotte, B. (2010) · La Revue de Médecine Interne · doi:10.1016/j.revmed.2009.12.020 · Cited by 31
Mechanism of Neuroinflammation: Enhanced Cytotoxicity and IL-17 Production via CD46 Binding
Yao, K., Graham, J., Akahata, Y., Oh, U., & Jacobson, S. (2010) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-010-9232-9 · Cited by 29
T‐helper 17 cell: A distinctive cell in liver diseases
Ye, C., Li, W., Zheng, M., & Chen, Y. (2010) · Hepatology Research · doi:10.1111/j.1872-034x.2010.00744.x · Cited by 28
Dendritic cells as therapeutic targets in neuroinflammation
Lüssi, F., Zipp, F., & Witsch, E. (2016) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-016-2170-9 · Cited by 29
Immunotherapy of Multiple Sclerosis: The State of the Art
Karussis, D. M. (2013) · BioDrugs · doi:10.1007/s40259-013-0011-z · Cited by 27
Metabolic response to glatiramer acetate therapy in multiple sclerosis patients
Riccardis, L. D., Ferramosca, A., Danieli, A., Trianni, G., Zara, V., Robertis, F. D., & Maffia, M. (2016) · BBA Clinical · doi:10.1016/j.bbacli.2016.10.004 · Cited by 27
“The animal model of MS, experimental autoimmune encephalomyelitis (EAE), the same used to synthesize the encephalitogenic components of myelin basic protein (MBP), was useful to understand that CD4 T cell subset plays a central role in MS pathogenesis [25], having these cells the ability to cross the blood–brain barri…”
Chang, J., Cha, H., Lee, D., Seo, K. Y., & Kweon, M. (2010) · PLoS ONE · doi:10.1371/annotation/6da7b65e-dda2-467d-bcb3-82d5669f6bc6 · Cited by 27
The role of the adaptive immune system in the initiation and persistence of multiple sclerosis
Afzali, A. M., & Korn, T. (2025) · Seminars in Immunology · doi:10.1016/j.smim.2025.101947 · Cited by 25
T cell-mediated skin-brain axis: Bridging the gap between psoriasis and psychiatric comorbidities
Yang, J., Zhang, S., Wu, Q., Chen, P., Dai, Y., Long, J., Wu, Y., & Lin, Y. (2024) · Journal of Autoimmunity · doi:10.1016/j.jaut.2024.103176 · Cited by 32
Moulton, C. D., Malys, M. K., Hopkins, C. W. P., Rokakis, A. S., Young, A. H., & Powell, N. (2024) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-024-01864-2 · Cited by 32
“Th17 cells and IL-17A have been found to increase the permeability of the blood–brain-barrier and induce neuroinflammation [81, 82].”
Role of T Follicular Helper cells in Multiple Sclerosis.
Schmitt, N. (2015) · PubMed · Cited by 31
Kim, Y., Kim, S. Y., Han, S.-M., Payumo, R. M. P., Park, K., Kim, H. E., Kim, S., Hyun, J., Lee, E., & Kim, H. J. (2021) · Science Translational Medicine · doi:10.1126/scitranslmed.abk2132 · Cited by 26
PP2A and Its Inhibitors in Helper T-Cell Differentiation and Autoimmunity
Khan, M. M., Ullah, U., Khan, M. H., & Lahesmaa, R. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2021.786857 · Cited by 28
“Th17 disrupts the BBB and promotes CNS inflammation (90).”
BackgroundNeuroinflammation: Extinguishing a blaze of T cells
Benallegue, N., Kébir, H., & Alvarez, J. I. (2022) · Immunological Reviews · doi:10.1111/imr.13122 · Cited by 26
Feizi, P., Sharma, K., Pasham, S. R., Nirwan, L., Joseph, J. T., Jaiswal, S., & Sriwastava, S. (2022) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2022.577939 · Cited by 26
Interleukin 22 and its association with neurodegenerative disease activity
Chen, W., Wang, J., Yang, H., Sun, Y., Chen, B., Liu, Y., Han, Y., Shan, M., & Zhan, J. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.958022 · Cited by 33
“TNF-α and IL-6, as previously indicated, aid in the recruitment and maintenance of inflammatory Th17 cells in the tissue (Kebir et al., 2007) and may contribute to disease development and progression (Paganelli et al.”
BackgroundRuder, J., Docampo, M. J., Rex, J., Obahor, S., Naghavian, R., Müller, A. M. S., Schanz, U., Jelčić, I., & Martinꝉ, R. (2022) · Science Translational Medicine · doi:10.1126/scitranslmed.abq1693 · Cited by 27
Role of Maternal Immune Factors in Neuroimmunology of Brain Development
Mohebalizadeh, M., Babapour, G., Aghdam, M. M., Mohammadi, T., Jafari, R., & Shafiei‐Irannejad, V. (2023) · Molecular Neurobiology · doi:10.1007/s12035-023-03749-2 · Cited by 31
Notch and Inflammatory T-cell Response: New Developments and Challenges
Mochizuki, K., He, S., & Zhang, Y. (2011) · Immunotherapy · doi:10.2217/imt.11.126 · Cited by 25
Farahani, R. H., Sarrafpour, B., Simonian, M. R., Li, Q., & Hunter, N. (2012) · The Journal of Comparative Neurology · doi:10.1002/cne.23162 · Cited by 28
Immunopathology of Japanese macaque encephalomyelitis is similar to multiple sclerosis
Blair, T. C., Manoharan, M., Rawlings-Rhea, S. D., Tagge, I., Kohama, S. G., Hollister‐Smith, J. A., Ferguson, B. M., Woltjer, R. L., Frederick, M. C., Pollaro, J., et al. (2015) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2015.11.026 · Cited by 27
“T cells expressing the cytokines IL-17 or IFN-γ appear to be key players in disease development, as studies have shown that these populations are present in MS lesions (Kebir et al., 2009, Tzartos et al., 2008, Kebir et al., 2007).”
BackgroundTeniente‐Serra, A., Grau‐López, L., Mansilla, M. J., Fernández, M. A., Condins, A. E., Ramo-Tello, C. M., & Martínez-Cáceres, E. M. (2016) · Autoimmunity · doi:10.3109/08916934.2016.1138271 · Cited by 25
Alphavirus Encephalomyelitis: Mechanisms and Approaches to Prevention of Neuronal Damage
Griffin, D. E. (2016) · Neurotherapeutics · doi:10.1007/s13311-016-0434-6 · Cited by 26
Interleukin 22 ameliorates neuropathology and protects from central nervous system autoimmunity
Mattapallil, M. J., Kielczewski, J. L., Zárate-Bladés, C. R., Leger, A. J. S., Raychaudhuri, K., Silver, P. B., Jittayasothorn, Y., Chan, C., & Caspi, R. R. (2019) · Journal of Autoimmunity · doi:10.1016/j.jaut.2019.04.017 · Cited by 25
“Of interest, IL-22R expression has been reported in primary cultures of endothelial cells of the blood brain barrier (BBB) [34] as well as in brain lesions of multiple sclerosis patients, where it co-localized with astrocytes, a cell type that is closely related to retinal glial Müller cells [25].”
BackgroundHan, Y., Sun, C.-Y., Meng, S., Tabarak, S., Yuan, K., Cao, L., Yan, W., Xu, L., Deng, J., Zhu, W., et al. (2019) · Molecular Psychiatry · doi:10.1038/s41380-019-0470-9 · Cited by 27
Neumann, S., Boothman-Burrell, L., Gowing, E. K., Jacobsen, T. A., Ahring, P. K., Young, S. L., Sandager‐Nielsen, K., & Clarkson, A. N. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.01133 · Cited by 29
“IL-17 also contributes to disruption of BBB tight junctions and neutrophil recruitment into the brain, resulting in further tissue damage (Kebir et al., 2007; Wang et al., 2009; Gelderblom et al., 2012).”
BackgroundRole of the thymus in autoimmune myasthenia gravis
Berrih‐Aknin, S. (2016) · Clinical and Experimental Neuroimmunology · doi:10.1111/cen3.12319 · Cited by 28
“Indeed, Th17 lymphocytes can transmigrate efficiently across blood–brain barrier endothelial cells and promote inflammation of the central nervous system.(88) In rheumatoid arthritis, the levels of IL-17 in joints correlate with disease severity, suggesting a role of IL-17 in the pathogenesis of this disease.”
BackgroundLiu, X., Ma, Q., Li, Q., Ou, C., Lin, Z., Lu, Y., Huang, H., Chen, P., Huang, Z., & Liu, W. (2020) · Clinical Immunology · doi:10.1016/j.clim.2020.108462 · Cited by 25
Rational design of siRNA-based delivery systems for effective treatment of brain diseases
Lu, D., Sun, Y., Luan, Y., & He, W. (2024) · Pharmaceutical Science Advances · doi:10.1016/j.pscia.2024.100041 · Cited by 28
Central inflammation versus peripheral regulation in multiple sclerosis
Edwards, L. J., Sharrack, B., Ismail, A., Tumani, H., & Constantinescu, C. S. (2011) · Journal of Neurology · doi:10.1007/s00415-011-5973-5 · Cited by 24
“Th17/Th1 cells) at the time of relapse has also been shown by other authors [1, 3], and it has been suggested that Th17 and Th17/Th1 cells migrate through the blood brain barrier [3, 28 ] and cause demyelination.”
ResultUlivieri, C., & Baldari, C. T. (2017) · Molecules · doi:10.3390/molecules22020225 · Cited by 25
Plasma cytokine profiling to predict susceptibility to acute mountain sickness
Lu, H., Wang, R., Li, W., Xie, H., Wang, C., Hao, Y., Sun, Y., & Jia, Z. (2016) · European Cytokine Network · doi:10.1684/ecn.2016.0383 · Cited by 24
“IL-17RA may therefore be impliated as a predictor of AMS-susceptibility at low altitude. s discussed above, impairment of the integrity of the lood-brain barrier (BBB) may play a crucial role in the evelopment of AMS.”
InfluentialAtypical optic neuritis: An overview
Sarkar, P., Mehtani, A., Gandhi, H., Dubey, V., Tembhurde, P., & Gupta, M. K. (2020) · Indian Journal of Ophthalmology · doi:10.4103/ijo.ijo_451_20 · Cited by 35
“Interestingly, two recent studies[43,44] have reported that Th17 cells also increased and might play a “collaborative” role in NMO.”
Dopaminergic Receptor Targeting in Multiple Sclerosis: Is There Therapeutic Potential?
Melnikov, M., Pashenkov, M. V., & Boyко, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22105313 · Cited by 24
Qiu, Y., Peng, Y.-P., Fang, X., Xu, F.-F., Liu, Z., & Cao, B. (2022) · Neural Regeneration Research · doi:10.4103/1673-5374.339490 · Cited by 28
“Moreover, IL-17 can disrupt BBB tight junctions and promote human Th17 cell infiltration into the brain (Kebir et al., 2007).”
IL-17 and TNF-β: Predictive biomarkers for transition to psychosis in ultra-high risk individuals
Ouyang, L., Li, D., Li, Z., Ma, X., Liu, Y., Fan, L., Yang, Z., Zhang, Z., Li, C., Hé, Y., et al. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.1072380 · Cited by 31
Metadata
- Authors
- Kebir, H., Kreymborg, K., Ifergan, I., Dodelet-Devillers, A., Cayrol, R., Bernard, M., Giuliani, F., Arbour, N., Becher, B., & Prat, A.
- Affiliations
- University of Zurich (CH)
- Hôpital Notre-Dame (CA)
- University of Alberta (CA)
- Corresponding author
- Prat, Alexandre
- Venue
- Nature Medicine
- Published
- 2007-09-09
- Volume
- 13
- Issue
- 10
- Pages
- 1173-1175
- ISSN
- 1078-8956 (ISSN-L)
- 1546-170X
- PMC
- PMC5114125
- OpenAlex
- W1998000193
- Semantic Scholar
- d0c491686d390e0dfdffedd4e32222d5b6065fd7
- Cited by
- 1,759
- References
- 14
- Citations by year
- 2026: 69 · 2025: 78 · 2024: 85 · 2023: 116 · 2022: 104 · 2021: 86 · 2020: 96 · 2019: 87 · 2018: 98 · 2017: 98 · 2016: 90 · 2015: 94 · 2014: 97 · 2013: 106 · 2012: 86
- FWCI
- 54.87
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Medicine (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Zurich Open Repository and Archive (University of Zurich) (submittedVersion)
- Funders
- Canadian Institutes of Health Research (79785_1)
- Topics
- Life Sciences › Neuroscience › Neurology › Barrier Structure and Function Studies
- Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
- Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
- Keywords
- Th17 cells, blood-brain barrier, endothelial cells, IL-17, IL-22, tight junctions, multiple sclerosis, neuroinflammation, lymphocyte transmigration, granzyme B
- MeSH terms
- Blood-Brain Barrier, Cell Membrane Permeability, Cell Movement, Cells, Cultured, Central Nervous System, Dose-Response Relationship, Drug, Endothelium, Vascular, T-Lymphocytes, Helper-Inducer, Humans, Inflammation, Multiple Sclerosis, CD4-Positive T-Lymphocytes, Case-Control Studies, Receptors, Interleukin, Tight Junctions, Interleukin-17, Endothelial Cells, Granzymes
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.